Literature DB >> 29736308

SPOCD1 promotes the proliferation and metastasis of glioma cells by up-regulating PTX3.

Quan Liu1, Xiao-Yu Wang2, Yuan-Yuan Qin3, Xian-Lei Yan1, Hong-Mou Chen1, Qi-Dan Huang1, Jia-Kang Chen1, Jie-Min Zheng1.   

Abstract

Gliomas are the most prevalent type of primary brain tumors in adults, accounting for more than 40% of neoplasms in the central nervous system. The spen paralogue and orthologue C-terminal domain containing 1 (SPOCD1) has been recently identified and found to discriminate progressive from non-progressive bladder cancers. In this study, we detected high-level of SPOCD1 expression in glioma and its high expression significantly associated with advanced tumor grade and poor prognosis. In vitro assays showed that knockdown of SPOCD1 significantly inhibited cell proliferation and colony formation capacities in U373 and U87 cells. In a xenograft model of glioma, SPOCD1 was also found to inhibit tumor growth. In addition, knockdown of SPOCD1 was shown to inhibit cell migration and invasion in glioma U373 and U87 cells. SPOCD1 positively regulated the expression of Pentraxin 3 (PTX3), whereas overexpression of PTX3 attenuated SPOCD1 knockdown-mediated inhibition of cell proliferation, migration and invasion in glioma cells. Our observations suggest that SPOCD1 promotes the proliferation and metastasis of glioma cells through regulating PTX3. Our data might provide novel evidence for the diagnosis and treatment of glioma in clinic.

Entities:  

Keywords:  PTX3; SPOCD1; glioma; metastasis; proliferation

Year:  2018        PMID: 29736308      PMCID: PMC5934553     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  22 in total

1.  ONCOMINE: a cancer microarray database and integrated data-mining platform.

Authors:  Daniel R Rhodes; Jianjun Yu; K Shanker; Nandan Deshpande; Radhika Varambally; Debashis Ghosh; Terrence Barrette; Akhilesh Pandey; Arul M Chinnaiyan
Journal:  Neoplasia       Date:  2004 Jan-Feb       Impact factor: 5.715

2.  Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes.

Authors:  Kouichi Kimura; Ai Wakamatsu; Yutaka Suzuki; Toshio Ota; Tetsuo Nishikawa; Riu Yamashita; Jun-ichi Yamamoto; Mitsuo Sekine; Katsuki Tsuritani; Hiroyuki Wakaguri; Shizuko Ishii; Tomoyasu Sugiyama; Kaoru Saito; Yuko Isono; Ryotaro Irie; Norihiro Kushida; Takahiro Yoneyama; Rie Otsuka; Katsuhiro Kanda; Takahide Yokoi; Hiroshi Kondo; Masako Wagatsuma; Katsuji Murakawa; Shinichi Ishida; Tadashi Ishibashi; Asako Takahashi-Fujii; Tomoo Tanase; Keiichi Nagai; Hisashi Kikuchi; Kenta Nakai; Takao Isogai; Sumio Sugano
Journal:  Genome Res       Date:  2005-12-12       Impact factor: 9.043

3.  Pentraxin-3 expression in acute renal allograft rejection.

Authors:  Naofumi Imai; Shinichi Nishi; Kazuhiro Yoshita; Yumi Ito; Yutaka Osawa; Kaori Takahashi; Yuki Nakagawa; Kazuhide Saito; Kota Takahashi; Ichiei Narita
Journal:  Clin Transplant       Date:  2012-07       Impact factor: 2.863

Review 4.  EMT: 2016.

Authors:  M Angela Nieto; Ruby Yun-Ju Huang; Rebecca A Jackson; Jean Paul Thiery
Journal:  Cell       Date:  2016-06-30       Impact factor: 41.582

5.  Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines.

Authors:  Jeongwu Lee; Svetlana Kotliarova; Yuri Kotliarov; Aiguo Li; Qin Su; Nicholas M Donin; Sandra Pastorino; Benjamin W Purow; Neil Christopher; Wei Zhang; John K Park; Howard A Fine
Journal:  Cancer Cell       Date:  2006-05       Impact factor: 31.743

6.  Stem cell-related "self-renewal" signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma.

Authors:  Anastasia Murat; Eugenia Migliavacca; Thierry Gorlia; Wanyu L Lambiv; Tal Shay; Marie-France Hamou; Nicolas de Tribolet; Luca Regli; Wolfgang Wick; Mathilde C M Kouwenhoven; Johannes A Hainfellner; Frank L Heppner; Pierre-Yves Dietrich; Yitzhak Zimmer; J Gregory Cairncross; Robert-Charles Janzer; Eytan Domany; Mauro Delorenzi; Roger Stupp; Monika E Hegi
Journal:  J Clin Oncol       Date:  2008-06-20       Impact factor: 44.544

7.  Pentraxin 3 Activates JNK Signaling and Regulates the Epithelial-To-Mesenchymal Transition in Renal Fibrosis.

Authors:  Tung-Wei Hung; Jen-Pi Tsai; Shin-Huey Lin; Chien-Hsing Lee; Yi-Hsien Hsieh; Horng-Rong Chang
Journal:  Cell Physiol Biochem       Date:  2016-12-12

8.  Intrinsic molecular subtypes of glioma are prognostic and predict benefit from adjuvant procarbazine, lomustine, and vincristine chemotherapy in combination with other prognostic factors in anaplastic oligodendroglial brain tumors: a report from EORTC study 26951.

Authors:  Lale Erdem-Eraslan; Lonneke A Gravendeel; Johan de Rooi; Paul H C Eilers; Ahmed Idbaih; Wim G M Spliet; Wilfred F A den Dunnen; Johannes L Teepen; Pieter Wesseling; Peter A E Sillevis Smitt; Johan M Kros; Thierry Gorlia; Martin J van den Bent; Pim J French
Journal:  J Clin Oncol       Date:  2012-12-26       Impact factor: 44.544

9.  Astrocyte elevated gene-1 interacts with Akt isoform 2 to control glioma growth, survival, and pathogenesis.

Authors:  Bin Hu; Luni Emdad; Manny D Bacolod; Timothy P Kegelman; Xue-Ning Shen; Mohammad A Alzubi; Swadesh K Das; Devanand Sarkar; Paul B Fisher
Journal:  Cancer Res       Date:  2014-10-10       Impact factor: 12.701

10.  Overexpression of FZD7 promotes glioma cell proliferation by upregulating TAZ.

Authors:  Xia Qiu; Jianguo Jiao; Yidong Li; Tian Tian
Journal:  Oncotarget       Date:  2016-12-27
View more
  14 in total

1.  Methylation silencing of ULK2 via epithelial-mesenchymal transition causes transformation to poorly differentiated gastric cancers.

Authors:  Iori Motoo; Sohachi Nanjo; Takayuki Ando; Satoshi Yamashita; Toshikazu Ushijima; Ichiro Yasuda
Journal:  Gastric Cancer       Date:  2021-09-23       Impact factor: 7.370

2.  RALY regulate the proliferation and expression of immune/inflammatory response genes via alternative splicing of FOS.

Authors:  Zhao Liang; Buzukela Abuduaini; Aliya Rehati; Erhati Husaiyin; Dong Chen; Zhang Jiyuan
Journal:  Genes Immun       Date:  2022-08-08       Impact factor: 4.248

3.  A Risk Model Developed Based on Homologous Recombination Deficiency Predicts Overall Survival in Patients With Lower Grade Glioma.

Authors:  Hao Peng; Yibiao Wang; Pengcheng Wang; Chuixue Huang; Zhaohui Liu; Changwu Wu
Journal:  Front Genet       Date:  2022-07-01       Impact factor: 4.772

4.  BORDER proteins protect expression of neighboring genes by promoting 3' Pol II pausing in plants.

Authors:  Xuhong Yu; Pascal G P Martin; Scott D Michaels
Journal:  Nat Commun       Date:  2019-09-25       Impact factor: 14.919

5.  An Arf/Rab cascade controls the growth and invasiveness of glioblastoma.

Authors:  Gopinath Kulasekaran; Mathilde Chaineau; Valerio Emilio Crescenzo Piscopo; Federica Verginelli; Maryam Fotouhi; Martine Girard; Yeman Tang; Rola Dali; Rita Lo; Stefano Stifani; Peter S McPherson
Journal:  J Cell Biol       Date:  2021-02-01       Impact factor: 10.539

6.  Pentraxin 3 is a diagnostic and prognostic marker for ovarian epithelial cancer patients based on comprehensive bioinformatics and experiments.

Authors:  Xiaoying Chang; Dan Li; Chang Liu; Zhe Zhang; Tao Wang
Journal:  Cancer Cell Int       Date:  2021-04-06       Impact factor: 5.722

7.  TNFSF13 Is a Novel Onco-Inflammatory Marker and Correlates With Immune Infiltration in Gliomas.

Authors:  Rui Chen; Xinxing Wang; Ziyu Dai; Zeyu Wang; Wantao Wu; Zhengang Hu; Xun Zhang; Zhixiong Liu; Hao Zhang; Quan Cheng
Journal:  Front Immunol       Date:  2021-10-12       Impact factor: 7.561

8.  A comprehensive prognostic signature for glioblastoma patients based on transcriptomics and single cell sequencing.

Authors:  Fan Fan; Hao Zhang; Ziyu Dai; Yakun Zhang; Zhiwei Xia; Hui Cao; Kui Yang; Shui Hu; Yong Guo; Fengqin Ding; Quan Cheng; Nan Zhang
Journal:  Cell Oncol (Dordr)       Date:  2021-06-17       Impact factor: 6.730

9.  High IER5 Gene Expression Is Associated With Poor Prognosis in Glioma Patients.

Authors:  Zijun Wu; Dan Wang; Fanxin Zeng; Yanrong Zhang; Guannan Zhu; Yiqi Ma; Bin Song; Su Lui; Min Wu
Journal:  Front Cell Dev Biol       Date:  2021-06-17

Review 10.  The Basic Characteristics of the Pentraxin Family and Their Functions in Tumor Progression.

Authors:  Zeyu Wang; Xing Wang; Hecun Zou; Ziyu Dai; Songshan Feng; Mingyu Zhang; Gelei Xiao; Zhixiong Liu; Quan Cheng
Journal:  Front Immunol       Date:  2020-08-18       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.